An Efficacy and Safety Study of Infliximab in Participants With Rheumatoid Arthritis
Clinical trial NCT00896168 · COMPLETED
Trial details
- NCT number
- NCT00896168
- Sponsor
- Xian-Janssen Pharmaceutical Ltd.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-01
- Primary completion
- 2008-04-01
- Enrollment
- 234
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.